• Conducted company and industry due diligence, created investment memos and analyzed prospective investee company financials to identify investment opportunities within the US-based AI healthcare sector• Performed various valuation methods, like DCF model and Comps analysis, to analyze company’s detailed financials of a theranostic cancer platform utilizing artificial intelligence (AI)• Drafted expansion strategy by analyzing 73 NCI-Designated Cancer Centers for collaboration opportunities

• Led a team of 6 clinical pharmacists to develop personalized chemotherapy plans for cancer patients, resulting in a 57% survival rate for regional lung cancer patients (up from 46%) and a 50% reduction in side effects• Launched an online medical platform providing medication consultation services and facilitated offline-to-online migration for over 85,000 patients since 2019, revolutionizing local medication consultation models• Designed a clinical decision support system to screen and analyze unreasonable prescriptions, reducing rate of unreasonable ones by 40%, patients’ average medical costs by 30%, and government penalties by $2M • Coordinated with 83 multidisciplinary specialists to online-manage 35,300+ chronic disease patients and successfully negotiated with 32 cross-department officials to deliver medications during the Covid-19 period • Initiated and managed lasting medical-support programs with 500+ volunteers to promote timely prevention and treatment of diseases across 89 communities, providing free online doctors for over 22,000 families